Rockefeller Capital Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7K Hold
370
﹤0.01% 3913
2026
Q1
$11.4K Buy
+370
New +$9.11K ﹤0.01% 3941
2022
Q1
Sell
-119
Closed -$5K 4097
2021
Q4
$5K Sell
119
-2,102
-95% -$121K ﹤0.01% 3296
2021
Q3
$148K Hold
2,221
﹤0.01% 1692
2021
Q2
$236K Hold
2,221
﹤0.01% 1451
2021
Q1
$338K Hold
2,221
﹤0.01% 1156
2020
Q4
$371K Hold
2,221
﹤0.01% 1011
2020
Q3
$346K Hold
2,221
﹤0.01% 902
2020
Q2
$465K Hold
2,221
﹤0.01% 723
2020
Q1
$415K Buy
+2,221
New +$523K 0.01% 646

Other funds holding TECX

Rockefeller Capital Management's TECX Position: Q2 2026 in Review

Rockefeller Capital Management held its Tectonic Therapeutic (TECX) position steady in Q2 2026 at 370 shares worth $12.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3913.

Rockefeller Capital Management first reported a position in TECX in Q1 2020 and has held it in 10 quarters since. The position peaked at $465K in Q2 2020. 123 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Rockefeller Capital Management held 370 shares of Tectonic Therapeutic worth $12.7K as of Q2 2026.
  • Rockefeller Capital Management left its Tectonic Therapeutic share count unchanged in Q2 2026.
  • Tectonic Therapeutic made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3913 holding.
  • Rockefeller Capital Management first reported a position in Tectonic Therapeutic in Q1 2020 and has held it in 10 quarters since.
  • Rockefeller Capital Management's Tectonic Therapeutic position peaked at $465K in Q2 2020.
  • 123 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.